187 related articles for article (PubMed ID: 27085860)
1. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
Rejeeth C; Salem A
J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
[TBL] [Abstract][Full Text] [Related]
2. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
3. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two silica based nonviral gene therapy vectors for breast carcinoma: evaluation of the p53 delivery system in Balb/c mice.
Rejeeth C; Vivek R
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):489-494. PubMed ID: 27111431
[TBL] [Abstract][Full Text] [Related]
5. p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles.
Rejeeth C; Kannan S
Breast Cancer; 2016 Jan; 23(1):101-110. PubMed ID: 24795076
[TBL] [Abstract][Full Text] [Related]
6. Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its antitumor effect in vitro and in vivo.
Wang W; Yao J; Zhou JP; Lu Y; Wang Y; Tao L; Li YP
Biochem Biophys Res Commun; 2008 Dec; 377(2):567-572. PubMed ID: 18929532
[TBL] [Abstract][Full Text] [Related]
7. A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells.
Misra SK; Naz S; Kondaiah P; Bhattacharya S
Biomaterials; 2014 Jan; 35(4):1334-46. PubMed ID: 24211075
[TBL] [Abstract][Full Text] [Related]
8. An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo.
Li YY; Wang R; Zhang GL; Zheng YJ; Zhu P; Zhang ZM; Fang XX; Feng Y
Cancer Gene Ther; 2007 Dec; 14(12):968-75. PubMed ID: 17853924
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
11. Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells.
Deng WG; Kawashima H; Wu G; Jayachandran G; Xu K; Minna JD; Roth JA; Ji L
Cancer Res; 2007 Jan; 67(2):709-17. PubMed ID: 17234782
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.
Prabha S; Labhasetwar V
Mol Pharm; 2004; 1(3):211-9. PubMed ID: 15981924
[TBL] [Abstract][Full Text] [Related]
13. Transfection with p21 and p53 tumor suppressor plasmids suppressed breast tumor growth in syngeneic mouse model.
Ibnat N; Kamaruzman NI; Ashaie M; Chowdhury EH
Gene; 2019 Jun; 701():32-40. PubMed ID: 30898703
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant lentivirus-mediated gene transfer of NT4-p53(N15)-Ant inhibits the growth of hepatocellular carcinoma cells in vitro].
Song LP; Li YP; Qiu SD; Wang N
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):10-6. PubMed ID: 20211059
[TBL] [Abstract][Full Text] [Related]
15. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
[TBL] [Abstract][Full Text] [Related]
16. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy.
Gaspar VM; Correia IJ; Sousa A; Silva F; Paquete CM; Queiroz JA; Sousa F
J Control Release; 2011 Dec; 156(2):212-22. PubMed ID: 21864596
[TBL] [Abstract][Full Text] [Related]
18. Combination wt-p53 and MicroRNA-125b Transfection in a Genetically Engineered Lung Cancer Model Using Dual CD44/EGFR-targeting Nanoparticles.
Talekar M; Trivedi M; Shah P; Ouyang Q; Oka A; Gandham S; Amiji MM
Mol Ther; 2016 Apr; 24(4):759-69. PubMed ID: 26686386
[TBL] [Abstract][Full Text] [Related]
19. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.
Xu J; Singh A; Amiji MM
BMC Cancer; 2014 Feb; 14():75. PubMed ID: 24507760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]